Fierce Healthcare August 23, 2019
Heather Landi

FDA official Amy Abernethy, M.D. said the agency is encouraging interoperability and wants to speed the development of new therapies and medical technologies.

The Food and Drug Administration is in discussions with multiple stakeholders to create a universal unique medical device identifier to be stored in electronic health records and linked to patient outcomes to improve medical device surveillance, said FDA principal deputy commissioner Amy Abernethy, M.D.

Speaking at the Office of the National Coordinator for Health IT’s 3rd Interoperability Forum in Washington, D.C., Abernethy, who also serves as the FDA’s acting CIO, said the agency wants to advance interoperability and speed the development of new therapies and medical technologies.

The FDA also is looking to provide regulatory relief to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: EMR / EHR, FDA, Govt Agencies, Health IT, HIE (Interoperability), Insurance, Medical Devices, ONC, Provider, Technology
Spinoffs, sales and tuck-ins top medtech deal priorities: Moody’s
Bayer and ASPIVIX collaborate on women’s health device
STAT+: Medicare official says breakthrough device reimbursement rule coming in early summer
Brain-computer interface research reaches new frontiers
Opinion: STAT+: How AI can help satisfy FDA’s drug, device diversity requirements

Share This Article